Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
937 GBX | +1.19% | +0.64% | +4.81% |
03-26 | Biotech Group Acquisition Withdraws IPO | DJ |
2023 | Biotech Growth's total return underperforms benchmark in tough market | AN |
Sales 2022 | -205M -256M -20.49B | Sales 2023 | -32.42M -40.49M -3.24B | Capitalization | 303M 379M 30.33B |
---|---|---|---|---|---|
Net income 2022 | -202M -252M -20.2B | Net income 2023 | -41M -51.22M -4.1B | EV / Sales 2022 | -1.96 x |
Net Debt 2022 | 31.74M 39.65M 3.17B | Net Debt 2023 | 17.4M 21.73M 1.74B | EV / Sales 2023 | -9.89 x |
P/E ratio 2022 |
-1.84
x | P/E ratio 2023 |
-7.64
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99.66% |
1 day | +1.19% | ||
1 week | +0.64% | ||
Current month | -5.83% | ||
1 month | -5.07% | ||
3 months | +2.52% | ||
6 months | +29.42% | ||
Current year | +4.81% |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffrey Hsu
BRD | Director/Board Member | - | 15/05/18 |
Roger Yates
CHM | Chairman | 67 | 30/11/21 |
Steve Bates
BRD | Director/Board Member | 66 | 07/07/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 937 | +1.19% | 32,552 |
25/04/24 | 926 | -2.53% | 48,374 |
24/04/24 | 950 | -0.21% | 51,910 |
23/04/24 | 952 | +2.92% | 53,195 |
22/04/24 | 925 | -0.64% | 58,909 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+4.81% | 390M | |
+3.27% | 14.32B | |
+3.12% | 6.21B | |
+12.72% | 4.4B | |
+10.97% | 4.36B | |
-7.52% | 4B | |
+3.61% | 3.51B | |
+8.55% | 3.22B | |
+7.91% | 3.06B | |
-1.91% | 2.77B |
- Stock Market
- Equities
- BIOG Stock